CoChat
Sign Up
Cited by 219Venous Thromboembolism Diagnosis and ManagementPituitary Gland Disorders and TreatmentsBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 62 of the 68 references it cites were found in a registry or an index.

Hypercoagulable State in Cushing’s Syndrome: A Systematic Review

Van Zaane, Bregje, Nur, Erfan, Squizzato, Alessandro, Dekkers, Olaf M., Twickler, Marcel (Th) B., Fliers, Eric, Gerdes, Victor E. A., Büller, Harry R., Brandjes, Dees P. M.·2009·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2009-0290
Open this paper in CoChat — free account

Abstract

CONTEXT: It has been debated whether an increased risk of venous thromboembolism (VTE) exists in patients with Cushing's syndrome. OBJECTIVE: We aimed to summarize published literature on the effects of endogenous hypercortisolism on coagulation and fibrinolysis, as well as on the clinical outcome of VTE. DATA SOURCES: We searched the MEDLINE and EMBASE databases up to July 2008. Review of reference lists further identified candidate studies. STUDY SELECTION: Two investigators independently performed study selection and data extraction. Eligible studies had to include Cushing's syndrome patients and either evaluate hemostatic parameters in comparison with control persons or posttreatment levels or describe the occurrence of VTE. DATA EXTRACTION: The Newcastle-Ottawa Scale was used to assess study quality. A scoring system divided studies into categories of low, medium and high quality. DATA SYNTHESIS: Of 441 identified publications, 15 reports were included. They contained information on eight cross-sectionals, two intervention, and eight cohort studies. No high-quality studies were identified. Hypercoagulability was suggested by high levels of factor VIII, factor IX, and von Willebrand factor and by evidence of enhanced thrombin generation. A risk of 1.9 and 2.5% was reported for VTE not provoked by surgery, whereas risk of postoperative VTE varied between 0 and 5.6%, with one outlier of 20%. VTE was reported as the cause of death in 0-1.9% of Cushing's syndrome patients. CONCLUSIONS: Available studies suggest a high risk of venous thrombosis in patients with Cushing's syndrome. Glucocorticoid-induced hypercoagulability as well as surgery and obesity almost certainly contribute to this thrombotic tendency.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2009-0290

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. Patil, 1993, to 2002, Neurosurg Focus, 23, E7

Cited by

Sorted by citations

See all 219

Related

See all

Metadata

Authors
Van Zaane, B., Nur, E., Squizzato, A., Dekkers, O. M., Twickler, M. (. B., Fliers, E., Gerdes, V. E. A., Büller, H. R., & Brandjes, D. P. M.
Affiliations
  • Slotervaartziekenhuis (NL)
  • University of Insubria (IT)
  • Leiden University Medical Center (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Department of Vascular Medicine (B.V.Z., A.S., M.B.T., V.E.A.G., H.R.B.), Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2009-08-01
Volume
94
Issue
8
Pages
2743-2750
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2009-0290
OpenAlex
W2116856478
Cited by
216
References
68
Citations by year
2026: 6 · 2025: 12 · 2024: 13 · 2023: 17 · 2022: 15 · 2021: 13 · 2020: 12 · 2019: 10 · 2018: 7 · 2017: 11 · 2016: 11 · 2015: 19 · 2014: 15 · 2013: 12 · 2012: 21
FWCI
2.57
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • IrInSubria (University of Insubria) (submittedVersion)
Topics
  • Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
Cushing's syndrome, hypercoagulability, venous thromboembolism, hypercortisolism, coagulation, fibrinolysis, factor VIII, factor IX, von Willebrand factor, thrombin generation, postoperative thrombosis, obesity, mortality
MeSH terms
Blood Coagulation, Cushing Syndrome, Fibrinolysis, Humans, Thrombophilia, Venous Thromboembolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review